Bio-identical Hormone & Peptide Specialists

Table of Contents
Cardio Res-Q Assessment from $775

Advanced labs, the Cleveland Heart panel and Dr. Varano’s evaluation:

South Asian Heart Disease Risk: Why It Is Higher and What Gets Checked

South Asian Heart Disease Risk: Why It Is Higher and What Gets Checked

People of South Asian ancestry have, on average, a higher risk of heart attack and stroke than most other groups, and heart disease tends to appear at a younger age. US cholesterol guidance has listed South Asian ancestry as a risk-enhancing factor for that reason.

This is a statement about large populations, not a prediction for any one person. Most of the extra risk traces back to familiar factors such as blood sugar, blood pressure and fat carried around the waist, and those can be measured and managed.

Key takeaways

  • Large studies find roughly double the rate of heart attack and stroke in South Asian adults compared with adults of European ancestry.
  • Standard risk calculators did not capture that difference in the largest study.
  • Diabetes, high blood pressure and central body fat explain much of the gap, and they often show up at a lower body weight.
  • Researchers have not found a risk factor unique to South Asian people.

Who the term covers

In heart research, South Asian usually means people whose families come from India, Pakistan, Bangladesh, Sri Lanka, Nepal, Bhutan or the Maldives. That is about a quarter of the world's population, with many languages, diets and ways of life.

The term is a research category. It is useful because it flags a pattern that would otherwise be hidden. An American Heart Association scientific statement points out that when all Asian Americans are counted as one group, the group looks lower risk, largely because of lower risk in East Asian populations. Looked at separately, South Asians have higher proportional death rates from artery disease than other Asian groups and non-Hispanic whites.1

What the population data show

The clearest numbers come from the UK Biobank, which followed 8,124 middle-aged adults of South Asian ancestry and more than 449,000 of European ancestry for a median of 11 years. None had known heart disease at the start.

Over that time, 6.8% of the South Asian participants had a heart attack, a stent or bypass procedure, or an ischemic stroke, compared with 4.4% of the European participants. After statistical adjustment, that worked out to about twice the risk.2

The higher relative risk was largely consistent across age groups, in men and women, and across clinical subgroups.

Earlier onset

Timing is part of the story. In the INTERHEART study, which compared heart attack patients in South Asian countries with patients in other parts of the world, the average age at a first heart attack was 53 in South Asian countries and about 59 elsewhere.

The researchers did not find a mysterious cause. The same nine risk factors explained most heart attacks in South Asians as in everyone else. The difference was that South Asian participants had more of those risk factors at younger ages. The authors concluded that this largely explains the earlier heart attacks.3

Why a risk calculator can read low

Here is the finding that matters most in a doctor's office. In the UK Biobank analysis, the 10-year risk predicted by standard US and UK calculators was nearly identical for South Asian and European participants, even though the observed risk was about twice as high.2

That gap is why guidelines add ancestry on top of the calculated number. The 2018 US cholesterol guideline included South Asian ancestry in its list of risk-enhancing factors, alongside items such as a family history of early heart disease and metabolic syndrome.4 A risk enhancer does not change the percentage. It is a reason for a clinician to look more closely when the number is borderline or intermediate.

The metabolic pattern

When the UK Biobank team looked at which factors accounted for the most risk, high blood pressure, diabetes and central adiposity, meaning fat carried around the abdomen, mattered more in South Asian participants than in European ones. The heart association statement reaches a similar view: most of the risk can be explained by known risk factors, especially those related to insulin resistance.1

Body weight can mislead here. A World Health Organization expert consultation concluded that a substantial share of Asian people are at high risk of type 2 diabetes and cardiovascular disease at a body mass index below 25, the usual cutoff for overweight.5 In plain terms, a weight that looks healthy on a standard chart does not rule out metabolic risk. Our page on insulin resistance explains what that term means and how it is assessed.

Lp(a)

Lipoprotein(a), or Lp(a), is an inherited cholesterol particle that a standard panel does not measure. In a seven-group analysis from INTERHEART, an Lp(a) level above 50 mg/dL was linked to about 48% higher odds of heart attack overall.

The share of heart attacks attributable to high Lp(a) was largest in South Asians, at 9.5%.6 Current US guidance is that every adult should have Lp(a) measured once. See our guide to the Lp(a) test for what the result means and what it cannot tell you.

What gets checked

CheckWhy it gets attention
Blood sugar and A1cDiabetes carried more weight as a risk factor in South Asian adults in the UK Biobank study
Blood pressureAlso a larger contributor in the same study
Waist size, not only weightRisk can be present at a lower body mass index
Cholesterol panel, with Lp(a) onceLp(a) is inherited and missed by routine testing
Family historyA parent or sibling with early heart disease adds to the picture

None of this is special testing. It is ordinary risk assessment done earlier and read with ancestry in mind. If relatives had heart disease young, see our guide to family history of early heart disease.

Your next step

If your calculated risk looks low but your ancestry or family history says otherwise, read our guide to the coronary calcium score, a scan clinicians sometimes use when a risk estimate is uncertain. The related reading below covers what a borderline or intermediate result means.

You can also answer the three quick questions in the screener on the Cardio Res-Q program page.

Cardiovascular Risk Screener

Are You a Candidate for Cardio Res-Q?

Three quick questions about the risk factors we screen for. Your answers stay between you and the clinic.

Frequently asked questions

Does this apply if I was born and raised in the United States?

The studies described here include people of South Asian ancestry living in the United Kingdom and the United States, not only people living in South Asia, and the higher risk was seen in them too. Where you grew up shapes diet, activity and access to care, so individual risk varies widely.

I am not overweight. Does the higher risk still apply to me?

It can. A World Health Organization expert group found that risk of type 2 diabetes and cardiovascular disease is substantial in Asian populations at a body mass index under 25. Waist size, blood sugar and blood pressure say more than the scale does.

Does South Asian ancestry mean I need cholesterol medication?

No. A risk-enhancing factor is a reason for a closer look, not an automatic prescription. Whether medication makes sense depends on your full risk picture and is a decision to make with your clinician.

Is there a gene that explains the higher risk?

No single cause has been identified. The American Heart Association statement says the biology of artery disease is no different in South Asians than in any other group, and that no risk factors unique to this population have been found.

Related reading

This article is for general education and is not medical advice. Decisions about testing and medication should be made with your clinician. If you have chest pain or other symptoms of a heart attack, call 911.

Optimize Your Health Today!

Cardio Res-Q starts with the $775 Comprehensive or $999 Enhanced Assessment, led by Dr. Varano.

age management doctor philadelphia
Send Us A Message
About Dr. Kenneth Varano, D.O.
age management doctor philadelphia

YoungerMeMD is a physician-led practice in Anti-Aging, Functional and Preventive Medicine, and your care is delivered by our whole clinical team. That team works under Medical Director Kenneth Varano, D.O., who brings over 30 years in clinical medicine and more than 20 years in age management and functional medicine — using science-backed, patient-focused strategies that restore balance, vitality, and health longevity.

About Barbara Dougherty
anti aging treatments

Barbara Dougherty, MSN, CRNP, is a Board-Certified Family Nurse Practitioner and Certified Menopause Practitioner (MSCP) specializing in optimizing hormones, and improving cardio-metabolic health. 

Read Our Reviews

“I’ve been seeing Dr. Varano for just over a year now, and I don’t think I’ve been this healthy and energetic since grade school.

Transform Your Health Today

Ready to take the first step toward renewed energy, balance, and longevity? New patients can register for an initial evaluation to begin their personalized anti-aging journey with YoungerMe MD. Live Younger. Better. Longer. — with YoungerMe MD.

References

  1. Volgman AS, et al. Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association. Circulation 2018. PMID 29794080 · doi:10.1161/CIR.0000000000000580↩
  2. Patel AP, et al. Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study. Circulation 2021. PMID 34247495 · doi:10.1161/CIRCULATIONAHA.120.052430↩
  3. Joshi P, et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 2007. PMID 17227980 · doi:10.1001/jama.297.3.286↩
  4. Grundy SM, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019. PMID 30586774 · doi:10.1161/CIR.0000000000000625↩
  5. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004. PMID 14726171 · doi:10.1016/S0140-6736(03)15268-3↩
  6. Paré G, et al. Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups. Circulation 2019. PMID 30667276 · doi:10.1161/CIRCULATIONAHA.118.034311↩
Book a Discovery Call Peptide Consult
Close
Book a Discovery Call
Close
Peptide Consult







    Transform Your
    Health & Wellness

    Fill up the form below to get started

      Provocation agent administered prior to timed urine collection (<6hr). Reveals toxic metal burden that can block hormone and peptide response.

      Identifies gluten sensitivity, intestinal permeability (leaky gut), and wheat-related immune reactivity – distinct from standard celiac testing.

      DNA Based stool test detecting pathogens, bacterial imbalances, parasites, and digestive markers – a comprehensive gut microbiome assessment.

      Non-invasive carotid artery ultrasound measuring arterial wall thickness – a direct look at your cardiovascular age.

      Cardio Res-Q cardiac risk panel – inflammation markers and cardiovascular biomarkers beyond standard labs.

      Evaluates intracellular vitamin, mineral, and antioxidant status – foundational to optimizing cellular health and peptide efficacy.

      Full Sex hormone, thyroid and adrenal picture. Identifies imbalances that affect energy, recovery, cognition, and peptide response.

      Advanced testing for immune reactions to wheat, gluten, and intestinal permeability.

      What It Evaluates

      Heavy metals like mercury, lead, cadmium, arsenic, and aluminum can cause:

      Conditions We Identify